CIK: 0001725042 · Show all filings
Period: Q4 2021 (Next →)
Filing Date: Feb 11, 2022
Total Value ($000): $104,681 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACHILLES THERAPEUTICS PLC | 11,086,909 | $55,545 | 53.1% | $5.01 | — | SPONSORED ADS | 00449L102 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 7,346,829 | $38,130 | 36.4% | $5.19 | — | SPON ADS | 05280R100 |
| — | FREELINE THERAPEUTICS HLDGS | 2,950,000 | $5,841 | 5.6% | $1.98 | — | SPONSORED ADS | 35655L107 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 1,377,294 | $5,165 | 4.9% | $3.75 | — | SPONDS ADR | 00653A107 |